Stay updated with breaking news from Pharmaceuticals Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fourth-Quarter 2023 Financial Results Revenue of $1.173 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $54 Million Adjusted EBITDA 1 of $231 Million Revenue Grew 18%...
Revenues of $1.007 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $84 Million Adjusted EBITDA 1 of $187 Million Revenues Grew 7% as Reported and 8% on a Constant...
Dechra Pharmaceuticals achieves strong organic growth in all key markets
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...